U.S. markets open in 5 hours 49 minutes

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
8.42-0.13 (-1.52%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 6/16/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 3-25.00%
S&P500 52-Week Change 336.67%
52 Week High 319.47
52 Week Low 36.84
50-Day Moving Average 37.80
200-Day Moving Average 38.60

Share Statistics

Avg Vol (3 month) 3211.76k
Avg Vol (10 day) 3138.68k
Shares Outstanding 520.19M
Implied Shares Outstanding 6N/A
Float 19.85M
% Held by Insiders 11.54%
% Held by Institutions 112.98%
Shares Short (May 27, 2021) 4857.11k
Short Ratio (May 27, 2021) 45.53
Short % of Float (May 27, 2021) 44.25%
Short % of Shares Outstanding (May 27, 2021) 44.24%
Shares Short (prior month Apr 29, 2021) 4864.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 10, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Aug 10, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-3,550.16%

Management Effectiveness

Return on Assets (ttm)-33.07%
Return on Equity (ttm)-59.29%

Income Statement

Revenue (ttm)622k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.93M
Net Income Avi to Common (ttm)-21.87M
Diluted EPS (ttm)-1.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)72.25M
Total Cash Per Share (mrq)3.58
Total Debt (mrq)634k
Total Debt/Equity (mrq)0.90
Current Ratio (mrq)17.71
Book Value Per Share (mrq)3.67

Cash Flow Statement

Operating Cash Flow (ttm)-21.41M
Levered Free Cash Flow (ttm)-13.28M